PRA Health Sciences (PRAH) PT Raised to $108 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
Go back to PRA Health Sciences (PRAH) PT Raised to $108 at Mizuho Securities
August 7, 2020 6:30 AM EDT
Credit Suisse analyst Erin Wilson Wright raised the price target on PRA Health Sciences (NASDAQ: PRAH) to $116.00 (from $113.00) while maintaining a Outperform rating.... More
August 7, 2020 4:32 AM EDT
Jefferies analyst David Windley raised the price target on PRA Health Sciences (NASDAQ: PRAH) to $130.00 (from $120.00) while maintaining a Buy rating.... More
August 6, 2020 5:33 PM EDT
PRA Health Sciences (NASDAQ: PRAH) reported Q2 EPS of $0.86, $0.03 better than the analyst estimate of $0.83. Revenue for the quarter came in at $729.9 million versus the consensus estimate of $716.72 million.
Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenueNet new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million of total revenue; representing a decrease of 4.4% at actual foreign exchange rates and 3.8% on a constant currency basis
Considering the very difficult circumstances, I was delighted with our second quarter financial results. We reported... More
